Status:
UNKNOWN
Does Levetiracetam and Carbamazepine Impact the Autonomic Activity of Children With Self-limiting Focal Epilepsy?
Lead Sponsor:
İpek Dokurel
Conditions:
Epilepsy; Syndrome, Seizures of Localized Onset
Eligibility:
All Genders
5-17 years
Brief Summary
The goal of this cross-sectional study is to learn about autonomic cardiac profile changes in children with self-limiting focal epilepsy using levetiracetam and carbamazepine in children with self-lim...
Detailed Description
Seventy-eight children with self-limiting focal epilepsy syndrome were enrolled in the study and were divided into two groups. Group I consisted of children with epilepsy who were only taking one type...
Eligibility Criteria
Inclusion
- Based on the ILAE classification, all children with epilepsy are categorized as self-limiting focal epilepsy syndromes.
Exclusion
- had signs of organic heart disease
- had other conditions that could influence the cardiovascular and autonomic nervous systems (such as systemic lupus erythematosus, and endocrine-metabolic abnormalities)
- use regular medications that have an impact on the cardiovascular and autonomic nervous systems
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 2 2023
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT06138847
Start Date
January 1 2023
End Date
December 2 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Balıkesir University Medical Faculty
Merkez, Balikesi̇r, Turkey (Türkiye), 10100